APOG APOGEE ENTERPRISES, INC.

Nasdaq apog.com


$ 38.42 $ -1.25 (-3.15 %)    

Wednesday, 22-Oct-2025 15:59:57 EDT
QQQ $ 603.94 $ 0.00 (0 %)
DIA $ 464.93 $ 0.00 (0 %)
SPY $ 667.27 $ 0.00 (0 %)
TLT $ 91.55 $ 0.00 (0 %)
GLD $ 380.24 $ 0.00 (0 %)
$ 38.45
$ 39.57
$ 38.14 x 15
$ 40.60 x 100
-- - --
$ 37.25 - $ 86.42
192,937
na
827.1M
$ 1.07
$ 18.61
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-09-2025 08-30-2025 10-Q
2 07-02-2025 05-31-2025 10-Q
3 04-24-2025 03-01-2025 10-K
4 01-07-2025 11-30-2024 10-Q
5 10-04-2024 08-31-2024 10-Q
6 07-09-2024 06-01-2024 10-Q
7 04-26-2024 03-02-2024 10-K
8 01-03-2024 11-25-2023 10-Q
9 10-04-2023 08-26-2023 10-Q
10 06-28-2023 05-27-2023 10-Q
11 04-21-2023 02-25-2023 10-K
12 12-29-2022 11-26-2022 10-Q
13 09-29-2022 08-27-2022 10-Q
14 07-01-2022 05-28-2022 10-Q
15 04-22-2022 02-26-2022 10-K
16 01-06-2022 11-27-2021 10-Q
17 09-30-2021 08-28-2021 10-Q
18 07-01-2021 05-29-2021 10-Q
19 04-22-2021 02-27-2021 10-K
20 01-07-2021 11-28-2020 10-Q
21 10-08-2020 08-29-2020 10-Q
22 07-09-2020 05-30-2020 10-Q
23 04-24-2020 02-29-2020 10-K
24 01-09-2020 11-30-2019 10-Q
25 10-03-2019 08-31-2019 10-Q
26 07-11-2019 06-01-2019 10-Q
27 04-26-2019 03-02-2019 10-K
28 01-10-2019 12-01-2018 10-Q
29 10-09-2018 09-01-2018 10-Q
30 07-12-2018 06-02-2018 10-Q
31 04-30-2018 03-03-2018 10-K
32 01-11-2018 12-02-2017 10-Q
33 10-12-2017 09-02-2017 10-Q
34 07-12-2017 06-03-2017 10-Q
35 04-28-2017 03-04-2017 10-K
36 01-05-2017 11-26-2016 10-Q
37 10-06-2016 08-27-2016 10-Q
38 07-07-2016 05-28-2016 10-Q
39 04-25-2016 02-27-2016 10-K
40 01-07-2016 11-28-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 levi-strauss-usana-health-sciences-and-3-stocks-to-watch-heading-into-friday

US stock futures up, Apogee Enterprises, Levi Strauss, VolitionRX, USANA Health Sciences, Nurix Therapeutics report results.

 apogee-enterprises-raises-fy2026-gaap-eps-guidance-from-259-312-to-279-319-vs-284-est

Apogee Enterprises (NASDAQ:APOG) raises FY2026 GAAP EPS guidance from $2.59-$3.12 to $2.79-$3.19 vs $2.84 analyst estimate..

 apogee-enterprises-lowers-fy2026-adj-eps-guidance-from-380-420-to-360-390-vs-395-est-lowers-fy2026-sales-guidance-from-1400b-1440b-to-1390b-1420b-vs-1427b-est

Apogee Enterprises (NASDAQ:APOG) lowers FY2026 Adj EPS guidance from $3.80-$4.20 to $3.60-$3.90 vs $3.95 analyst estimate. Lowe...

 apogee-enterprises-q2-adj-eps-098-beats-084-estimate-sales-358194m-beat-351700m-estimate

Apogee Enterprises (NASDAQ:APOG) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimate of $0...

 da-davidson-maintains-neutral-on-apogee-enterprises-lowers-price-target-to-45

DA Davidson analyst Brent Thielman maintains Apogee Enterprises (NASDAQ:APOG) with a Neutral and lowers the price target fro...

 apogees-ceo-expects-to-mitigate-tariffs-later-this-year-lifts-forecast

Apogee Enterprises (APOG) reported strong first-quarter fiscal 2025 results, with revenue up 4.6% and adjusted EPS of 56 cents,...

 us-stocks-likely-to-open-higher-as-commerce-secretary-confirms-deal-with-china-nike-worthington-steel-surge-amid-upbeat-earnings

U.S. futures rose on Friday following Thursday's rally. Futures of major benchmark indices were trading higher.

 apogee-enterprises-raises-fy2026-adj-eps-guidance-from-355-410-to-380-420-vs-374-est-raises-fy2026-sales-guidance-from-1370b-1430b-to-1400b-1440b-vs-1388b-est

Fiscal 2026 OutlookThe Company is raising its outlook for the fiscal year for both net sales and diluted EPS. The Company now e...

 apogee-enterprises-q1-adj-eps-056-beats-047-estimate-sales-34662m-beat-32548m-estimate

Apogee Enterprises (NASDAQ:APOG) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION